Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver

2024/11/09 by Alison C. MacKinnon, Duncan C. Humphries, Kimberley Herman +12 · 7 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #Galectins and Cancer Biology #Glycosylation and Glycoproteins Research #Studies on Chitinases and Chitosanases

paper · doi:10.1016/j.ejphar.2024.177077

Cited by

• Galectins in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential
• Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH -Wildtype Glioblastoma. [europepmc]
• Dysregulation of the FGF21-Adiponectin Axis in a Large Cohort of Patients with Severe Obesity and Liver Disease. [europepmc]
• Circulating and Tissue Galectin-3 in Gastrointestinal Inflammation: Clinical Significance and Biomarker Potential. [europepmc]
• TGFβ enhances platelet-breast-cancer-cell interaction and promotes platelet aggregation. [europepmc]
• Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications. [europepmc]
• Galectin-3-A Multifunctional Molecule and a Key Player in Health and Disease. [europepmc]